Form 4: Angiodynamics Executive Reports Stock Transaction
Insider Transaction (Form 4)
Warren Nighan Jr, SVP Quality and Regulatory of Angiodynamics Inc, reported multiple transactions in common stock on July 22, 2026.
Summary
- Option exercise/conversion: acquired 5,694 Common Stock on July 22, 2026; holds 89,786 after (Direct).
- Tax/exercise-price withholding: disposed of 1,671 Common Stock at $13.82 ($23,093) on July 22, 2026; holds 88,115 after (Direct).
- Option exercise/conversion: disposed of 20,052 Performance Right on July 22, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Warren Nighan Jr — Officer (SVP Quality and Regulatory)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-22 | Option exercise/conversion | Common Stock | 5,694 | — | — | 89,786 |
| 2026-07-22 | Tax/exercise-price withholding | Common Stock | 1,671 | $14 | $23.1K | 88,115 |
| 2026-07-22 | Option exercise/conversion | Performance Right | 20,052 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-22 | Option exercise/conversion (5,694 shares) |
| 2026-07-22 | Tax/exercise-price withholding (1,671 shares) |
| 2026-07-22 | Option exercise/conversion (20,052 shares) |
Keywords
insider transaction, Form 4, ANGO, ANGIODYNAMICS INC, neutral, Warren Nighan Jr
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.